Annie Rebibo-Sabbah

Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations

Igor Nudelman, Annie Rebibo-Sabbah, Marina Cherniavsky et al. · Journal of Medicinal Chemistry · 2009 · 184 citations · Full text

Premature Translational Termination, Genetics, Molecular Biology +20

Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations

Igor Nudelman, Annie Rebibo-Sabbah, D. Shallom-Shezifi et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 77 citations

Genetic Diseases, Genetic Disorder, Medicine +11

Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives

Shiran Yehezkel, Annie Rebibo-Sabbah, Yardena Segev et al. · Epigenetics · 2011 · 74 citations · Full text

Epigenetic Change, Genetics, Telomeric Regions +19

In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome

Annie Rebibo-Sabbah, Igor Nudelman, Zubair M. Ahmed et al. · Human Genetics · 2007 · 73 citations

Type 1, Mendelian Disorder, Genetic Disorder +9

Beneficial Read-Through of a<i>USH1C</i>Nonsense Mutation by Designed Aminoglycoside NB30 in the Retina

Tobias Goldmann, Annie Rebibo-Sabbah, Nora Overlack et al. · Investigative Ophthalmology & Visual Science · 2010 · 52 citations

Ocular Disease, Genetics, Molecular Biology +17